Skip to content

Flavored filling in yiqi decoction phlegmy wet block type polycystic ovary syndrome prospective randomized controlled clinical study

Flavored filling in yiqi decoction phlegmy wet block type polycystic ovary syndrome prospective randomized controlled clinical study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-16009166
Enrollment
Unknown
Registered
2016-09-06
Start date
2016-09-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome

Interventions

Experimental group:Yiqi soup flavored filling
The control group:metformin

Sponsors

Changhai Hospital of Shanghai
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
16 Years to 35 Years

Inclusion criteria

Inclusion criteria: (1) in line with the western medicine diagnosis of PCOS standard. (2) phlegmy wet block type of traditional Chinese medicine diagnosis standard; (3) for ages 16 and 35 years old; (4) voluntarily to participat the experiment, and signed informed consent.

Exclusion criteria

Exclusion criteria: (1) does not comply with the western medicine diagnostic criteria, the diagnosis of other causes of anovulatory continuously, high androgen and insulin resistance (insulin to hold, IR) disease, such as reproductive organs implement qualitative sex pathological change, the hypothalamus sex amenorrhoea;Cortisol increased disease, idiopathic hirsutism; (2) do not conform to the standard of syndromes of traditional Chinese medicine; (3) taking nearly 3 month of English - 35, metformin, spironolactone and other drugs; Nearly a month take antibiotics and probiotics;Nearly a month to promote gastrointestinal drugs such as: more Pan Li ketone amine, methoxychlor tome, xisha will benefit, etc.; (4) serious damage to tumor and other organs, thyroid and other endocrine disease, nearly a month, diarrhea or other gastrointestinal tract diseases, has a history of gastrointestinal surgery patients with PCOS.

Design outcomes

Secondary

MeasureTime frame
Body mass index;Waist hip ratio;hairy;acne;A skin;Fasting plasma glucose;Index of insulin antagonism;Sex determination;Core flora in the gut;Chronic inflammatory factor levels;

Primary

MeasureTime frame
Ovulation rate;

Contacts

Public ContactChaoqin Yu

Changhai hospital affiliated to Shanghai

chqyu81@163.com+86 13818390984

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026